Gamma interferon-induced, nitric oxide-mediated inhibition of vaccinia virus replication
about
Nitric oxide inhibits HIV tat-induced NF-kB activationCytokine production associated with smallpox vaccine responsesThe role of myeloid cell activation and arginine metabolism in the pathogenesis of virus-induced diseasesAdverse events post smallpox-vaccination: insights from tail scarification infection in mice with Vaccinia virusEffect of nitric oxide on poliovirus infection of two human cell lines.Does nitric oxide play a critical role in viral infections?Study of Dengue virus infection in SCID mice engrafted with human K562 cells.Disassociation between the in vitro and in vivo effects of nitric oxide on a neurotropic murine coronavirusInhibition of Japanese encephalitis virus infection by nitric oxide: antiviral effect of nitric oxide on RNA virus replicationProphylactic DNA vaccine for hepatitis C virus (HCV) infection: HCV-specific cytotoxic T lymphocyte induction and protection from HCV-recombinant vaccinia infection in an HLA-A2.1 transgenic mouse model.Herpes Simplex Virus 1 Suppresses the Function of Lung Dendritic Cells via Caveolin-1Protection against lethal vaccinia virus challenge in HLA-A2 transgenic mice by immunization with a single CD8+ T-cell peptide epitope of vaccinia and variola viruses.Interleukin-18 protects mice against acute herpes simplex virus type 1 infection.CD8 T cells use IFN-γ to protect against the lethal effects of a respiratory poxvirus infection.Resistance to murine hepatitis virus strain 3 is dependent on production of nitric oxideIntrahepatic induction of alpha/beta interferon eliminates viral RNA-containing capsids in hepatitis B virus transgenic miceThe murine double-stranded RNA-dependent protein kinase PKR is required for resistance to vesicular stomatitis virus.Inhibition of influenza virus replication by nitric oxideNitric oxide inhibits rhinovirus-induced cytokine production and viral replication in a human respiratory epithelial cell line.CD11b⁺, Ly6G⁺ cells produce type I interferon and exhibit tissue protective properties following peripheral virus infectionElevated generation of reactive oxygen/nitrogen species in hantavirus cardiopulmonary syndrome.Use of a recombinant vaccinia virus expressing interferon gamma for post-exposure protection against vaccinia and ectromelia virusesActivity of nitric oxide-generating compounds against encephalomyocarditis virus.Shared modes of protection against poxvirus infection by attenuated and conventional smallpox vaccine viruses.Evaluation of non-reciprocal heterologous immunity between unrelated virusesInnate immune responses to cytomegalovirus infection in the developing mouse brain and their evasion by virus-infected neurons.A recombinant vaccinia virus encoding inducible nitric oxide synthase is attenuated in vivo.Distinct organ-dependent mechanisms for the control of murine cytomegalovirus infection by natural killer cells.Inhibition of viral replication by nitric oxide and its reversal by ferrous sulfate and tricarboxylic acid cycle metabolites.Novel cell type-specific antiviral mechanism of interferon gamma action in macrophagesSuppression of herpes simplex virus type 1 (HSV-1)-induced pneumonia in mice by inhibition of inducible nitric oxide synthase (iNOS, NOS2)Prophylactic vaccine strategies and the potential of therapeutic vaccines against herpes simplex virusDevelopment of severe pathology in immunized pregnant mice challenged with lethal malaria parasitesNitric oxide inhibits viral replication in murine myocarditis.Nitric oxide inhibition of coxsackievirus replication in vitro.The importance of local mucosal HIV-specific CD8(+) cytotoxic T lymphocytes for resistance to mucosal viral transmission in mice and enhancement of resistance by local administration of IL-12.Vesicular stomatitis virus infection of the central nervous system activates both innate and acquired immunity.Colonization of xenograft tumors by oncolytic vaccinia virus (VACV) results in enhanced tumor killing due to the involvement of myeloid cells.Interleukin-12 (IL-12) enhancement of the cellular immune response against human immunodeficiency virus type 1 env antigen in a DNA prime/vaccinia virus boost vaccine regimen is time and dose dependent: suppressive effects of IL-12 boost are mediatePichinde virus induces microvascular endothelial cell permeability through the production of nitric oxide.
P2860
Q23923154-42F3B25B-215B-41C0-BECA-DE25CB96933BQ26823501-C5148030-213A-4D67-9FD9-0C04026C18A6Q26859106-2C167FD2-ECF2-4AA9-85A0-F23B245D0332Q27346800-1AA9E03B-DA9A-45D3-82D8-ECAFFBE96FB9Q27469534-8AC8C121-35AA-432E-8C30-6770266A0C84Q27469563-8382EA31-81A4-4D2C-B0F6-5C17137058F1Q27469587-CB2CA94E-3A16-476E-9450-F381D94E6E79Q27480796-F41BFDB9-392E-49D6-AA58-30902B8FB7F5Q27480830-80B4335D-FAFF-4570-8966-C6F302C0FF82Q27488288-39E42066-D5A3-4B92-85C4-2CBD94E421E5Q28384657-80C0202C-CD1C-4FB0-AE33-6457C4D65834Q30449492-F1909E52-F182-4613-820B-00F852EEA8E3Q33653786-80180642-D684-4DD9-9F75-95CEDAE8E0B5Q33677183-3614C807-882A-4258-8B17-DC38B96A26C8Q33783752-00F2C72F-5101-473E-B051-7BE4032833E5Q33803549-A3EEFC00-2828-4799-A98B-1D18F21BA009Q33811639-A1407AF4-D56F-4E5B-AB61-5985A5216DB2Q33821697-397FA1AA-AA97-4C6A-9D60-3F053E7A48EEQ34068980-004D2EB2-5BDC-4890-9F8E-EED923616FE3Q34079167-05810975-D7B2-443D-B728-14535CE76139Q35000452-02512FF6-4651-4C13-B522-0497B0341547Q35023470-44A63926-3498-41B4-8204-C8BAD006130EQ35124050-077B1885-AA00-4A96-942E-C3CB339DAFE9Q35234767-3FC6A20D-2D58-4BE2-9CD8-78805E1B8797Q35706798-DF439501-AE2C-4CB2-BDB2-85961FFE544BQ35789158-79F4F75A-F6A3-471D-950A-D778D3701D91Q35872019-E4AB635A-76B3-4D64-B4FB-48A55F837755Q35874845-F2F221E6-89F2-4DDD-ABFC-C3E367903029Q36364935-9D74CA78-4E82-4BD2-911B-2E5E81E4A3C8Q36376172-B060B542-E214-4C7B-BC2E-2851F920F8CAQ36377165-FF2AFD44-1CEE-49E2-A404-51B23A4EB51CQ36879345-9EAF9AD4-EE83-480E-A1EA-1AFAD462B09EQ37264727-8A4673E2-00D3-481A-B4D6-7D47171B7D4DQ37354157-391FD36F-75B4-4BCC-BB96-D8750EA9837DQ37372893-1C4977FF-D398-44DB-8261-726022EF4E74Q37388157-29774572-6CE4-43FC-96D5-5E64DE2C7815Q38291063-BC651179-46C3-4E4C-9688-4091AA98AFB0Q39389295-AB779E65-26D0-41FF-9BFD-5E43342FF9A3Q39591919-567D02AE-9735-4DE1-84D1-9DA68662EB3EQ39789959-94AD8967-8B7C-4D28-92B7-B64D2D773A24
P2860
Gamma interferon-induced, nitric oxide-mediated inhibition of vaccinia virus replication
description
1995 nî lūn-bûn
@nan
1995年の論文
@ja
1995年論文
@yue
1995年論文
@zh-hant
1995年論文
@zh-hk
1995年論文
@zh-mo
1995年論文
@zh-tw
1995年论文
@wuu
1995年论文
@zh
1995年论文
@zh-cn
name
Gamma interferon-induced, nitric oxide-mediated inhibition of vaccinia virus replication
@ast
Gamma interferon-induced, nitric oxide-mediated inhibition of vaccinia virus replication
@en
type
label
Gamma interferon-induced, nitric oxide-mediated inhibition of vaccinia virus replication
@ast
Gamma interferon-induced, nitric oxide-mediated inhibition of vaccinia virus replication
@en
prefLabel
Gamma interferon-induced, nitric oxide-mediated inhibition of vaccinia virus replication
@ast
Gamma interferon-induced, nitric oxide-mediated inhibition of vaccinia virus replication
@en
P2093
P2860
P1433
P1476
Gamma interferon-induced, nitric oxide-mediated inhibition of vaccinia virus replication
@en
P2093
P2860
P304
P407
P577
1995-02-01T00:00:00Z